ArticlemedRxiv : the preprint server for health sciences2025
Thalamic stereoelectroencephalography: safety, accuracy, and thalamocortical connectivity.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Background and Objectives: There is growing interest in thalamic sampling during epilepsy stereoelectroencephalography (sEEG). Data on thalamic sEEG safety, accuracy, and anterior (ANT), centromedian (CM), and pulvinar (PUL) nucleus connectomics is scarce. Here, we report the safety, accuracy and connectivity of thalamic sEEG and compare results to epilepsy DBS. Methods: This single-center study included all patients with epilepsy implanted with thalamic sEEG or DBS between 2018 and 2024. Stereo-EEG surgery used a frameless stereotactic articulating arm, 3D printed stereotactic guide, or robot (sEEG lead diameter 0.8mm). DBS surgery used a rigid frame and cannula (1.81mm outer diameter). Post-surgical complications were identified by chart and imaging review. For each thalamic lead, accuracy was defined as the distance from the nearest electrode contact to the targeted nucleus Morel atlas volume (ANT, CM, or PUL), using an open-source toolbox. Estimated volumes of tissue activation/sampling were calculated for each most proximate contact for thalamocortical connectivity analysis. Connectivity analyses used a normative structural connectome, and connectivity patterns were compared. Results: 160 thalamic sEEG leads and 188 DBS leads were implanted across 109 and 83 patients, respectively. One sEEG patient (0.9%) developed a symptomatic intraparenchymal hemorrhage with transient weakness of the contralateral upper extremity. Eight patients with DBS had transient post-surgical symptomatic complications, three with radiographic findings. Targeting accuracy was excellent for sEEG and DBS with median proximity of 0.30mm and 0.23mm, respectively; sEEG was associated with greater variability and more outliers (proximity≥3mm; 4% vs. 0, Discussion: Thalamic sEEG demonstrates a favorable safety profile, excellent targeting accuracy, and representative thalamocortical network engagement relative to DBS. Favorable sEEG safety profile may reflect difference in lead cross-sectional area (5.1-fold smaller than DBS cannula). Distinct ANT, CM, and PUL thalamocortical connectivity profiles support individualized, hypothesis-driven targeting.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.